Abstract：
Hidradenitis suppurativa (HS) is a chronic inflammatory follicular disease characterized by painful, recurrent, inflamed lesions most commonly occurring in the axillary, inguinal, and anogenital regions. HS can inflict immense physical and psychological impact on patients who suffer from this distressing disease. Management of HS generally requires combining various medical and procedural treatment modalities; however, the disease is often recalcitrant to conventional treatments. In light of recent evidence supporting the effectiveness of biologic agents in the treatment of HS, the Taiwanese Dermatological Association established an expert panel of nine dermatologists to develop consensus statements aimed to provide up-to-date evidence-based guidance in optimizing HS patient management in Taiwan. The recommendations described in the statements were summarized in a management algorithm in terms of general care, topical treatment, systemic treatment, and procedural treatment.
摘要：
化脓性汗腺炎（HS）是一种慢性炎症性滤泡疾病，其特征是疼痛，经常性,炎症病变最常见于腋窝，腹股沟,和肛门生殖器区域。HS可以对患有这种令人痛苦的疾病的患者造成巨大的身体和心理影响。HS的管理通常需要结合各种医疗和程序治疗方式；然而，这种疾病通常难以接受常规治疗。鉴于最近的证据支持生物制剂治疗HS的有效性，台湾皮肤病学会成立了一个由9名皮肤科医师组成的专家小组,以制定共识声明,旨在为优化台湾HS患者管理提供最新的循证指导.声明中描述的建议在一般护理方面的管理算法中进行了总结，局部治疗,全身治疗,和程序化治疗。
